Sources

9 Total Sources

Novartis Buys Myricx Bio for Up to $1.5 Billion to Add Experimental Cancer Drug

Left50%
Center33%
Right17%
Bloomberg6h ago
Novartis to Acquire Myricx Bio for Up to $1.5 Billion for Cancer Drug
The Wall Street Journal6h ago
Novartis to Buy Myricx Bio for Up to $1.5 Billion - WSJ
Malone Telegram12h ago
Myricx Bio to be Acquired by Novartis to Advance Next-Generation ADC Payloads for Oncology with Novel NMTi Platform | Press Releases | mymalonetelegram.com
AOL6h ago
Novartis to acquire UK-based Myricx Bio for up to $1.5 billion - AOL
baha news6h ago
Novartis acquires Myricx Bio in $1.5B deal - Breaking The News
Markets Insider6h ago
Brandon Capital Announces Agreement for Novartis to Acquire Portfolio Company Myricx Bio to Advance New Class of Cancer Therapeutics | Markets Insider
Marketscreener.com6h ago
Novartis to Buy Myricx Bio for Up to $1.5 Billion | MarketScreener
The National Tribune6h ago
Brandon Capital Announces Agreement for Novartis to Acquire Portfolio Company Myricx Bio to Advance New Class of Cancer Therapeutics | The National Tribune
financialcontent.com8h ago
Sofinnova Partners Announces Myricx Bio Agrees to Be Acquired by Novartis | FinancialContent